HealthTree University: Know Your Therapy (BETA) (Part 1 of 3)
These videos are still in the editing stages, but they they have important information about your disease and the myeloma therapies patients commonly receive. So we have released the un-edited clips here early for you to enjoy.
Every myeloma therapy comes with its own surprises! Dosing, scheduling, side effects, combinations of the drug with other drugs; these are all factors to consider when selecting and going through your myeloma therapy. We interviewed some of the top myeloma doctors in the world to bring you up-to-date information about your disease and its treatment. Revlimid, Pomalyst Thalomid and Velcade are some of the most common myeloma therapies and you should have the information you need when making decisions about your care.
Below are some video excerpts from our HealthTree University curriculum to help you learn more about these important areas of your disease. We invite you to watch them all, and also visit HealthTree University and creating a HealthTree account. By creating a HealthTree account, in HealthTree University you can:
- Save and keep track of your progress in the courses
- Get points for answering quiz questions
- Bookmark videos
- Take notes
- Earn prizes [COMING SOON]
- And get access to all the other incredible features of HealthTree!
10.01 All About Revlimid (Lenalidomide)
10.02 All About Pomalyst (Pomalidomide)
10.03 All About Thalomid (Thalidomide)
10.04 All About Velcade (Bortezomib)
We’d like to thank our faculty who donated their time in creating these videos, including:
- Maria Chaudhry, MBBS of The Ohio State University Comprehensive Cancer Center
- Srinivas Devarakonda, MD of The Ohio State University Comprehensive Cancer Center
We have over 200 HealthTree University videos online at university.healthtree.org! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
Other HealthTree University Classes:
10 Know Your Therapy [BETA]
14 MRD Testing
19 COVID-19 and Multiple Myeloma [BETA]